Opinion
Video
Author(s):
Panelists discuss how atopic dermatitis (AD) presents differently across skin tones, appearing as purple, gray, or barely visible inflammation rather than classic redness, with perifollicular prominence and postinflammatory pigmentation changes being more prominent in patients with darker skin.
Content above is prompted by the following:
AD presents with distinct clinical features across different skin tones that require specialized recognition skills for accurate diagnosis. In patients with darker skin, inflammation appears as light purple, dark purple, gray, or may be nearly invisible against darker background pigmentation, contrasting with the classic red appearance in patients with lighter skin. Health care providers must expand their diagnostic criteria beyond erythema to recognize this broader spectrum of inflammatory presentations and avoid missed diagnoses in diverse populations.
Certain morphological features are more prominent in patients with skin of color, including perifollicular prominence manifesting as bumps around hair follicles rather than typical patches. These papular presentations can be the primary manifestation of AD in patients with darker skin tones, requiring clinicians to recognize these variant presentations. Postinflammatory hyerpigmentation represents another critical consideration, as affected areas may become lighter or darker than native skin tone, persisting long after active inflammation resolves and causing significant patient distress.
Disparities in care often result from delays in accessing specialist treatment, leading to more severe disease presentations in many patients with skin of color. Complex social determinants of health, environmental factors, and health care access barriers contribute to seeing more severe lichenification, popular nodules, and greater overall quality-of-life impacts. These factors are not primarily biological but reflect systemic health care inequities that require targeted interventions to ensure equitable access to appropriate dermatologic care and specialized treatments.
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.